Material Update In Connection With IGL Spirits Limited With Reference To Observation Lefter No. NSE/LIST/48932 Dated 17T November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19" November, 2025 ("Observation Letters'), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The "Stock Exchanges'), Respectively, Received In Relation To The Scheme Of Arrangement.

Material Update In Connection With Ennature Bio Pharma Limited With Reference To Observation Letter No. NSE/LIST/48932 Dated 17T November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19" November, 2025 ("Observation Letters'), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The

Fixation Of Effective Date And Record Date For Scheme Of Arrangement.

Fixation Of Effective Date And Record Date For Scheme Of Arrangement.

Announcement under Regulation 30 (LODR)-Newspaper Publication

Receipt Of Certified True Copy Of NCLT Order

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Shareholder Meeting / Postal Ballot-Outcome of AGM

Clarification On BSE Query On Volume Movement.

Clarification For NSE Query On Spurt In Volumes

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Reminder For Mandatory Furnishing Of PAN, KYC Details And Nomination For Holders Of Physical Securities.

Board Meeting Outcome for Outcome Of The Board Meeting

Announcement under Regulation 30 (LODR)-Change in Management

Intimation Of Q1FY27 Earnings Conference Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Closure of Trading Window

Board Meeting Intimation for Consider And Approve The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The First Quarter Ended 30Th June, 2026.

Material Update In Connection With IGL Spirits Limited (Wholly Owned Subsidiary) With Reference To Observation Letter No. NSE/LIST/48932 Dated 17Th November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19Th November, 2025 ("Observation Letters"), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The "Stock Exchanges"), Respectively, Received In Relation To The Scheme Of Arrangement.

Material Update In Connection With Ennature Bio Pharma Limited With Reference To Observation Letter No. NSE/LIST/48932 Dated 17Th November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19Th November, 2025 ("Observation Letters"), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The "Stock Exchanges"), Respectively, Received In Relation To The Scheme Of Arrangement.